Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients.

about

Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients.

Item

http://www.wikidata.org/entity/Q55387022

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients.

@en

Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients.

@nl

type

Item

label

Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients.

@en

Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients.

@nl

prefLabel

Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients.

@en

Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients.

@nl

P1476

Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients

@en

P2093

Akihiro Tsutsumi

http://www.w3.org/2001/XMLSchema#string

Hidefumi Koh

http://www.w3.org/2001/XMLSchema#string

Hidehiro Irie

http://www.w3.org/2001/XMLSchema#string

Hidetoshi Nakamura

http://www.w3.org/2001/XMLSchema#string

Kaori Sakurai

http://www.w3.org/2001/XMLSchema#string

Koichiro Asano

http://www.w3.org/2001/XMLSchema#string

Naofumi Kameyama

http://www.w3.org/2001/XMLSchema#string

Takashi Kamatani

http://www.w3.org/2001/XMLSchema#string

Takeshi Terashima

http://www.w3.org/2001/XMLSchema#string

Tomoko Betsuyaku

http://www.w3.org/2001/XMLSchema#string

P2860

Exacerbations of COPD

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.

Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease.

Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors.

Predictors of mortality in elderly subjects with obstructive airway disease: the PILE score

Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury.

Management of chronic obstructive pulmonary disease beyond the lungs.

Validity of the COPD assessment test translated into local languages for Asian patients.

Neutrophil-to-lymphocyte ratio, calprotectin and YKL-40 in patients with chronic obstructive pulmonary disease: correlations and 5-year mortality - a cohort study

P2888

s12890-018-0639-z

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12890-018-0639-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shotaro Chubachi

P577

2018-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103764505

http://www.w3.org/2001/XMLSchema#string

P698

29720140

http://www.w3.org/2001/XMLSchema#string

P921

lymphocyte

P932

5932787

http://www.w3.org/2001/XMLSchema#string